期刊文献+

一例神经纤维瘤病Ⅰ型患者NF1基因新的插入缺失型突变 被引量:4

A novel indel NF1 mutation identified in a patient with neurofibromatosis type 1
原文传递
导出
摘要 目的 对1例临床拟诊为神经纤维瘤Ⅰ型(neurofibromatosis type 1,NF-1)患者进行致病基因突变研究.方法 通过探针杂交富集患者神经纤维蛋白1 (neurofibromin 1,NF1)基因的全部编码区外显子及其旁侧序列进行高通量测序确定可疑突变,并用Sanger测序法对核心家系成员的相应目标基因区域进行测序验证.结果 在患者NF1基因的第8外显子检出一插入/缺失型突变(indel)c.789790delAGinsT(p.K263Nfs* 18),造成突变点后的三联密码子阅读框发生改变而导致蛋白质翻译的提前终止.其表型正常父母均无此改变.在患者突变点下游第8内含子中还检出两个源自父亲的杂合多态性改变c.888+ 108C>T(rs2953000)和c.888+ 118G>T(rs2952999),Sanger测序峰图显示这三处改变位于同一染色体.结论 c.789_790delAGinsT为来自父源的新生突变,确定为患者的致病原因,从而肯定临床诊断.该突变类型补充了NF1基因的突变数据库.比较Sanger测序技术,目标区域二代测序进行NF1基因突变检测,更为快捷、价廉和高效,适用于临床. Objective To identify the genetic etiology in a Chinese patient with neurofibromatosis type 1 (NF-1).Methods All coding exons and the flanking sequences of neurofibromin 1 (NF1)gene from the patient were captured,individually barcoded and subjected to HiSeq2000 high-throughput sequencing.Suspected mutation was validated in the nuclear family members with Sanger sequencing.Results A novel indel mutation,c.789_790delAGinsT,was identified in the exon 8 of the NF1 gene in the patient but not in her asymptomatic parents.The mutation was predicted to have caused shifting of the reading frame and a premature downstream stop codon (p.K263Nfs * 18).Two known polymorphisms,c.888 + 108 C〉 T (rs2953000) and c.888 +118 G〉T (rs2952999),was detected in the flanking of the indel mutation in the patient and her father.Sequencing chromatogram for the family indicates that above changes are located on the same chromosome.Conclusion The c.789_790delAGinsT,as a de novo mutation occurring on the paternally derived chromosome,is most likely to be causative for the disease.Compared with Sanger sequencing,targeted next-generation sequencing is more efficient and can dramatically reduce the cost for the genetic testing of NF-1.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2015年第3期318-322,共5页 Chinese Journal of Medical Genetics
基金 国家自然科学基金(31350005) 中国医学科学院青年基金(3332013033)
关键词 神经纤维瘤病I型 神经纤维蛋白1基因 目标区域二代测序 基因突变 Neurofibromatosis type 1 Neurofibromin 1 gene Targeted next-generationsequencing Gene mutation
  • 相关文献

参考文献15

  • 1Williams VC, Lucas J, Babcock MA, et al. Neurofibromatosis type 1 revisited[J]. Pediatrics, 2009, 123(1) :124-133.
  • 2National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md, USA, July 13- 15, 1987[J]. Neurofibromatosis, 1988, 1(3):172-178.
  • 3Buchberg AM, Cleveland LS, Jenkins NA, et al. Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway [J]. Nature, 1990, 347(6290):291-294.
  • 4Xu GF, O'Connell P, Viskochil D, et aL The neurofibromatosis type 1 gene encodes a protein related to GAP[J]. Cell, 1990, 62 (3) :599 -608.
  • 5Stenson PD, Mort M, Ball EV, et al. The Human Gene Mutation Database: building a comprehensive mutation repository or clinical and molecular genetics, diagnostic testingand personalized genomic medicine[J]. Hum Genet, 2014, 133 (1) :1-9.
  • 6YangT, Meng Y, Wei X, et al. Identification of novel mutations of PKD1 gene in Chinese patients with autosomal dominant polycystic kidney disease by targeted next-generation sequencing[J]. Clin Chim Acta, 2014, 433 : 12-19.
  • 7Trovo-Marqui AB, Tajara EH. Neurofibromin.. a general out|ook[J]. Clin Genet, 2006, 70(1) :1-13.
  • 8Cunha KS, Barboza EP, Fonseca EC. Identification of growth hormone receptor in plexiform neurofibromas of patients with neurofibromatosis type [J]. Clinics (Sao Paulo), 2008, 63(1) : 39-42.
  • 9Cappione AJ, French BL, Skuse GR. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors[J]. Am J Hum Genet, 1997, 60(2):305-312.
  • 10Crowe FW, Schull WJ, Neel JV. A clinical, pathological and genetic study of multiple neurofibromatosis[M]. Springfield, Ill. USA.. Charles C Thomas Publisher, 1956:153- 154.

同被引文献28

  • 1李昌亚,朱颖,赵厚育.I型神经纤维瘤病1例报告[J].中国科技期刊数据库 医药,2016(7):108-108. 被引量:1
  • 2Williams VC,Lucas J,Babcock MA,et al.Neurofibromatosis type 1 revisited[J].Pediatrics,2009,123(1):124-133.
  • 3Jett K,Friedman JM.Clinical and genetic aspects of neurofibromatosis 1[J].Genet Med,2010,12(1):1-11.
  • 4National Institutes of Health Consensus Development Conference Statement:neurofibromatosis.Bethesda,Md,USA,July 13-15,1987[J].Neurofibromatosis,1988,1(3):172-178.
  • 5Buchberg AM,Cleveland LS,Jenkins NA,et al.Sequence homology shared by neurofibromatosis type-1gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway[J].Nature,1990,347(6290):291-294.
  • 6Xu GF,OConnell P,Viskochil D,et al.The neurofibromatosis type 1 gene encodes a protein related to GAP[J].Cell,1990,62(3):599-608.
  • 7Wei X,Ju X,Yi X,et al.Identification of sequence variants in genetic disease-causing genes using targeted next-generation sequencing[J].Plos One,2011,6(12):e29500.
  • 8Wei X,Dai Y,Yu P,et al.Targeted next-generation sequencing as a comprehensive test for patients with and female carriers of DMD/BMD:a multi-population diagnostic study[J].Eur J Hum Genet,2014,22(1):110-118.
  • 9Upadhyaya M,Spurlock G,Monem B,et al.Germline and somatic NF1 gene mutations in plexiform neurofibromas[J].Hum Mutat,2008,29(8):E103-111.
  • 10Upadhyaya M,Osborn MJ,Maynard J,et al.Mutational and functional analysis of the neurofibromatosis type 1(NF1)gene[J].Hum Genet,1997,99(1):88-92.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部